drugset / Trial / NCT04306302

A Study to Evaluate the Different Doses of VAC52416 (ExPEC10V) in Japanese Adults

NCT04306302

Phase 1 Completed 24 enrolled Janssen Pharmaceutical K.K.
RandomizedSequentialDouble-blindPrevention

Summary

The purpose of this study is to evaluate the safety and reactogenicity of different doses of extraintestinal pathogenic Escherichia coli 10 valent (ExPEC10V) in Japanese participants greater than or equal to (\>=) 60 to less than or equal to (\<=) 85 years of age.

Timeline

Start
2020-03-13
Primary completion
2020-12-24
Completion
2020-12-24

Drugs

EvaluationDrugModalityDoseRoute
Subject ExPEC10V Vaccine Intramuscular

Indications

No indication recorded.